NCT05007808 - Efficacy and Safety of G001 in Patients With Osteoarthritis (OA) of the Knee | Biotech Hunter

Enrollment

210

Participants

Timeline

Start Date

January 6, 2021

Primary Completion Date

January 4, 2023

Study Completion Date

January 10, 2023

Conditions

Osteoarthritis, Knee

Interventions

DRUG

G001 Topical Gel

Non-steroidal anti-inflammatory drug for topical administration

DRUG

Vehicle

Vehicle Gel for topical administration

Trial Locations (10)

Aggarwal and Associates Limited, Brampton

Medicor Research Inc., Greater Sudbury

Manna Research, Lévis

Recherche GCP Research, Montreal

Alpha recherche Clinique (1), Québec

Alpha Recherche Clinique (2), Québec

Centre de Recherche Saint-Louis, Québec

G.R.M.O. (Groupe de Recherche en Maladie Osseuses) Inc., Québec

Recherche Clinique Sigma Inc., Québec

Canadian Phase Onward Inc., Toronto